India's Symbiotec Pharmalab declines after Q1 profit fall
22/09/2026 04:58
BUZZ-India's Symbiotec Pharmalab declines after Q1 profit fall ** Shares of Symbiotec Pharmalab SYMI.NS down 3.11% at 1,120.10 rupees after reporting first results since IPO
** Stock could snap three consecutive sessions of gains
** Co reports 53% decline in quarterly net profit to 141.56 million rupees ($1.48 million)
** Reports Q1 revenue from operations of 2.18 billion rupees vs 2.03 billion rupees in the year-ago period
** The drag on EBITDA was mainly due to expenses from new businesses which are yet to generate significant traction--analysts at ICICI Direct Research
** Shares up 13.4% since trading debut on September 1
($1 = 95.8100 Indian rupees)
(Reporting by Saikeerthi in Bengaluru)
((Saikeerthi@thomsonreuters.com; (+91) 8296756080))
Recent news on Symbiotec Pharmalab
See all newsIndia's Symbiotec Pharmalab rises on US drug distribution deal
Brief: Symbiotec Pharmalab Unit Enters Into Strategic Commercialization Agreement
Brief: Symbiotec Pharmalab Receives U.S. FDA Eir For Pithampur Facility With Vai Status
India's Symbiotec Pharmalab declines after Q1 profit fall
India's Symbiotec Pharmalab rises after muted debut, valued at $779 million